CURO Biosciences Pvt Ltd

Non Invasive Easy Early Detection of Cancer through Saliva.

  • Stage Full Product Ready
  • Industry Biotechnology
  • Location Nagpur, Maharashtra, India
  • Currency INR
  • Founded August 2019
  • Employees 6
  • Incorporation Type Other
  • Website erlysign.com

Company Summary

Curo Biosciences is a Biotech startup based in Nagpur.And is working on developing non invasive early detection test kits for fatal diseases like Oral cancer, Breast Cancer, Uterine cancer, Prostate cancer, Lung Cancer, HIV, Alzheimer’s and many more.
Our first test kit “Erlysign” is a prognostic test kit for Oral pre cancer( Fibrosis, Leukoplakia, Erythroplakia, Lichen Planus) & Oral Squamous Cell Carcinoma i.e Oral Cancer.

Team

  • Shubhendra Thakur
    Founder & CEO

  • Dr Deovrat Begde
    Cofounder & Chief Clinical Officer

    PHD in Biochemistry, more then 15 years of experience in research and teaching in Biochem and Biotech,Have multiple research papers published on various national and international journals,Holds various indian patents on his name.Awarded by Protein society of Boston as young investigator award.

  • Dr Sunita Bundale
    Head Microbiologist

    PHD in Microbiology and more then 20 years of working experience in research and teaching in field of microbiology. Multiple patents as well as research papers published in various national international journals.

  • Arpita parakh
    Data Analyst

    Msc in Bioinformatics & Mtech in Computational Biology. Experienced in data analysis and interpretation through genome sequencing.

  • Dr Aparna Nair
    Scientific Team Lead

Previous Investors

  • Hemanshu Jain
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free